121 related articles for article (PubMed ID: 8227414)
21. Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas.
Crocker J; Egan MJ
J Pathol; 1988 Nov; 156(3):233-9. PubMed ID: 3060577
[TBL] [Abstract][Full Text] [Related]
22. [The grouping of morphological variants of non-Hodgkin's lymphomas (lymphosarcomas) by the degree of malignancy].
Sotnikov VM; Kharchenko VP; Pan'shin GA; Galil-Ogly GA; Zakharova LV; Teĭblium MM
Klin Med (Mosk); 1996; 74(2):41-3. PubMed ID: 8772102
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of 82 patients with non-Hodgkin's lymphoma--mainly on the evaluation of therapeutic efficacy].
Kakinoki Y; Maekawa I; Kawamura T; Miyake T; Kurosawa M; Okabe M; Kamiya K; Sasaki O
Hokkaido Igaku Zasshi; 1987 Dec; 62(6):841-50. PubMed ID: 3443427
[TBL] [Abstract][Full Text] [Related]
24. [Primary gastrointestinal non-Hodgkin's lymphoma in two Hungarian regions].
Kollár B; Rajnics P; Hunyady B; Zeleznik E; Jakucs J; Egyed M
Orv Hetil; 2009 Aug; 150(35):1649-53. PubMed ID: 19692309
[TBL] [Abstract][Full Text] [Related]
25. [Non-Hodgkin's lymphomas. II. Prognostic factors].
San Miguel JF; Tomás JF; Martín MJ; Ríos A; Moraleda JM; Cañizo MC; González M; Nieto MJ; Sánchez J; López Borrasca A
Sangre (Barc); 1988 Oct; 33(5):367-71. PubMed ID: 3247618
[No Abstract] [Full Text] [Related]
26. [M-BACOD in advanced case of non-Hodgkin's lymphoma].
Itami J; Ogata H; Shimizu K; Nemoto K; Yasuda S; Yoshida H; Mikata A; Arimizu N
Gan No Rinsho; 1990 Mar; 36(4):499-504. PubMed ID: 1690824
[TBL] [Abstract][Full Text] [Related]
27. P-COMM-B induction chemotherapy in intermediate and high grade non-Hodgkin's lymphoma.
Phillips JK; Sherlaw-Johnson C; Davies JM; Clough JV; Parry H; Nash JR; Cawley JC
Leuk Lymphoma; 1995 Jun; 18(1-2):137-43. PubMed ID: 8580816
[TBL] [Abstract][Full Text] [Related]
28. Semi-automatic quantitation of nucleolar organizer regions in non-Hodgkin's lymphomas.
Kalir T; Chan KS; Liu Z; Strauchen J; Gil J
Pathol Res Pract; 1994 Feb; 190(2):124-8. PubMed ID: 7520162
[TBL] [Abstract][Full Text] [Related]
29. [Weekly CHOP chemotherapy in the treatment of intermediate-grade non-Hodgkin's lymphomas--cooperative group study by seven institutes].
Kobayashi M; Sao H; Mizuta S; Kamiya O; Ohara K; Nagata K; Takeyama H; Watanabe E; Yamada H; Mizuno H
Rinsho Ketsueki; 1990 Oct; 31(10):1656-63. PubMed ID: 2255056
[TBL] [Abstract][Full Text] [Related]
30. Nucleolar organizer regions of lymphomas in Korea.
Kim I; Park SH; Paik SY
J Korean Med Sci; 1988 Sep; 3(3):99-105. PubMed ID: 2477040
[TBL] [Abstract][Full Text] [Related]
31. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
[TBL] [Abstract][Full Text] [Related]
32. Sequential demonstration of nucleolar organizer regions and Ki67 immunolabelling in non-Hodgkin's lymphomas.
Janmohamed RM; Murray PG; Crocker J; Leyland MJ
Clin Lab Haematol; 1990; 12(4):395-9. PubMed ID: 2081380
[TBL] [Abstract][Full Text] [Related]
33. The importance of nucleolar organizer regions in pediatric acute lymphoblastic leukemia.
Patiroglu T; Karakukcu M; Ilten A; Imamoglu N
Pediatr Hematol Oncol; 2004 Dec; 21(8):685-95. PubMed ID: 15739623
[TBL] [Abstract][Full Text] [Related]
34. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
[TBL] [Abstract][Full Text] [Related]
35. Nucleolar organizer regions in aspirates of malignant lymphomas and benign disorders of the lymph nodes.
Xu LZ; Wang LF
Anal Quant Cytol Histol; 1992 Apr; 14(2):148-52. PubMed ID: 1590898
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szajowski K
Acta Otorhinolaryngol Belg; 1998; 52(3):215-21. PubMed ID: 9810456
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the patterns of argyrophilic nucleolar organiser regions (AgNORs) in primary gastric lymphomas.
Bufo P; Minervini MI; Frassanito F
Boll Soc Ital Biol Sper; 1992 Oct; 68(10):625-31. PubMed ID: 1295518
[TBL] [Abstract][Full Text] [Related]
39. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
